Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia.

Saved in:
Bibliographic Details
Title: Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia.
Authors: Romanová T; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.; Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Burša F; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.; Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Sklienka P; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.; Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Sagan J; Department of Infectious Diseases, University Hospital Ostrava, Ostrava, Czech Republic., Vaňková M; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic., Buršík D; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.; Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Bílená M; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.; Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Pulcer M; Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic., Burda M; Institute for Research and Applications of Fuzzy Modeling, CE IT4Innovations, University of Ostrava, Ostrava, Czech Republic., Máca J; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.; Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Institute of Physiology and Pathophysiology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
Source: Therapeutics and clinical risk management [Ther Clin Risk Manag] 2024 Sep 10; Vol. 20, pp. 611-618. Date of Electronic Publication: 2024 Sep 10 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101253281 Publication Model: eCollection Cited Medium: Print ISSN: 1176-6336 (Print) Linking ISSN: 11766336 NLM ISO Abbreviation: Ther Clin Risk Manag Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39280635
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Romanová+T%22">Romanová T</searchLink>; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.; Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Burša+F%22">Burša F</searchLink>; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.; Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Sklienka+P%22">Sklienka P</searchLink>; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.; Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Sagan+J%22">Sagan J</searchLink>; Department of Infectious Diseases, University Hospital Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Vaňková+M%22">Vaňková M</searchLink>; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Buršík+D%22">Buršík D</searchLink>; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.; Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Bílená+M%22">Bílená M</searchLink>; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.; Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Pulcer+M%22">Pulcer M</searchLink>; Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Burda+M%22">Burda M</searchLink>; Institute for Research and Applications of Fuzzy Modeling, CE IT4Innovations, University of Ostrava, Ostrava, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Máca+J%22">Máca J</searchLink>; Department of Anesthesiology and Intensive Care Medicine, University Hospital, Ostrava, Czech Republic.; Department of Intensive Medicine, Emergency Medicine and Forensic Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.; Institute of Physiology and Pathophysiology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101253281%22">Therapeutics and clinical risk management</searchLink> [Ther Clin Risk Manag] 2024 Sep 10; Vol. 20, pp. 611-618. <i>Date of Electronic Publication: </i>2024 Sep 10 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Medical+Press%22">Dove Medical Press </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101253281 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1176-6336 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211766336%22">11766336 </searchLink><i>NLM ISO Abbreviation: </i>Ther Clin Risk Manag <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39280635
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/TCRM.S476187
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 611
    Titles:
      – TitleFull: Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Romanová T
      – PersonEntity:
          Name:
            NameFull: Burša F
      – PersonEntity:
          Name:
            NameFull: Sklienka P
      – PersonEntity:
          Name:
            NameFull: Sagan J
      – PersonEntity:
          Name:
            NameFull: Vaňková M
      – PersonEntity:
          Name:
            NameFull: Buršík D
      – PersonEntity:
          Name:
            NameFull: Bílená M
      – PersonEntity:
          Name:
            NameFull: Pulcer M
      – PersonEntity:
          Name:
            NameFull: Burda M
      – PersonEntity:
          Name:
            NameFull: Máca J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 09
              Text: 2024 Sep 10
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 1176-6336
          Numbering:
            – Type: volume
              Value: 20
          Titles:
            – TitleFull: Therapeutics and clinical risk management
              Type: main
ResultId 1